Synonyms: Example 1 [WO2014183520A1] | SHR-6390 | SHR6390
dalpiciclib is an approved drug (China (2021))
Compound class:
Synthetic organic
Comment: The chemical structure submitted to the WHO for the INN dalpiciclib is identical to that of the orally administered CDK4/6 inhibitor SHR6390, via a PubChem structure match. Pharmacological and preclinical anti-tumour data for SHR6390 have been published [1,3], albeit without name>structure disclosure. SHR6390 was designed by Jiangsu Hengrui Medicine Company.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (China (2021)) |
IUPAC Name |
6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperidin-4-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one |
International Nonproprietary Names | |
INN number | INN |
11428 | dalpiciclib |
Synonyms |
Example 1 [WO2014183520A1] | SHR-6390 | SHR6390 |
Database Links | |
GtoPdb PubChem SID | 434122249 |
PubChem CID | 86279927 |
Search Google for chemical match using the InChIKey | SGJLSPUSUBJWHO-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SGJLSPUSUBJWHO |
Search PubMed clinical trials | dalpiciclib |
Search PubMed titles | dalpiciclib |
Search PubMed titles/abstracts | dalpiciclib |
UniChem Compound Search for chemical match using the InChIKey | SGJLSPUSUBJWHO-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SGJLSPUSUBJWHO-UHFFFAOYSA-N |